Researchers find better predictor of breast cancer

Researchers find better predictor of breast cancer
Graham A. Colditz, MD, DrPH, is one of the developers of the Rosner-Colditz statistical model, an improved method to predict a woman’s risk of developing breast cancer.

(Medical Xpress)—Epidemiologists have designed a better method to quantify a woman's risk of developing breast cancer, according to researchers at Washington University School of Medicine in St. Louis and their collaborators. The model could help identify women at high risk of breast cancer who may benefit from prevention strategies that reduce the chances of developing the disease.

"Over the past 20 years, we have worked to develop a more complete model for classifying risk of ," said Graham A. Colditz, MD, DrPH, associate director for cancer prevention and control at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University. "The next step is to incorporate it into clinical practice so we can improve prevention."

The model validation appears online in the journal Breast Cancer Research and Treatment.

The Rosner-Colditz model for breast cancer considers well-established factors known to contribute to , including body mass index, alcohol consumption and age at first menstrual period. But the model also includes information not considered in other prediction methods, such as a woman's age at menopause and the type of menopause, whether natural or surgical (following the removal of ovaries).

According to the study, the Rosner-Colditz model outperforms the most commonly used model by 3 to 5 percent. The researchers verified the accuracy of their model using data from the California Teachers Study, which includes information about the development of breast cancer in more than 130,000 teachers over a 14-year period.

The model was most accurate for women ages 47 to 69 and for predicting the likelihood that a woman would develop breast cancer in the next five years. Similar to other models, the performance of the Rosner-Colditz model dropped off for women age 70 and older and for predicting breast over longer periods of time.

Colditz, who is also the Niess-Gain Professor of Surgery, said the is most useful for helping to stratify risk and identify women who are much more likely than average to receive a breast cancer diagnosis in the next five years.

"One-quarter of all breast cancer cases are diagnosed in the 10 percent of women at highest risk in any five-year age group," Colditz said. "These are the women who will benefit most from interventions that are known to reduce risk."

Interventions that reduce breast cancer risk include lifestyle changes such as weight loss and increased physical activity. Doctors who know they have a high-risk patient also have preventive options that include increased surveillance and treatments that influence the way the body uses or makes estrogen, such as drugs like tamoxifen, raloxifene and aromatase inhibitors.

Colditz said he and his colleagues are working to integrate this type of risk modeling into clinical care at the Joanne Knight Breast Health Center so that when a woman comes in for her yearly mammogram, she also is given an estimate of her risk of developing breast cancer over the next five years. The Knight Breast Health Center is part of the Siteman Cancer Center.

More information: Rosner BA, Colditz GA, Hankinson SE, Sullivan-Halley J, Lacey Jr. JV, Bernstein L. Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study. Breast Cancer Research and Treatment. November 2013.

Related Stories

Recommended for you

Understanding your kidney tumor in 3D

2 hours ago

Most patients rely on their doctors to decipher the black, white and gray images on their CT scans. But what if a patient could instead hold a 3D model made from the CT image in his hands? Suddenly, the picture ...

Biomarker in aggressive breast cancer identified

16 hours ago

Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, ...

MRI better detects recurrent breast cancer

17 hours ago

(HealthDay)—Single-screening breast magnetic resonance imaging (MRI) detects 18.1 additional cancers after negative findings with mammography and ultrasonography (US) per 1,000 women with a history of breast ...

User comments